Carey DE - Search Results

1

The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells.

Kim M, Sumerel LA, Belousova N, Lyons GR, Carey DE, Krasnykh V, Douglas JT. Kim M, et al. Among authors: carey de. Br J Cancer. 2003 May 6;88(9):1411-6. doi: 10.1038/sj.bjc.6600932. Br J Cancer. 2003. PMID: 12778071 Free PMC article.

2

Efficient oncolysis by a replicating adenovirus (ad) in vivo is critically dependent on tumor expression of primary ad receptors.

Douglas JT, Kim M, Sumerel LA, Carey DE, Curiel DT. Douglas JT, et al. Among authors: carey de. Cancer Res. 2001 Feb 1;61(3):813-7. Cancer Res. 2001. PMID: 11221860

3

Adenoviral gene therapy for renal cancer requires retargeting to alternative cellular receptors.

Haviv YS, Blackwell JL, Kanerva A, Nagi P, Krasnykh V, Dmitriev I, Wang M, Naito S, Lei X, Hemminki A, Carey D, Curiel DT. Haviv YS, et al. Cancer Res. 2002 Aug 1;62(15):4273-81. Cancer Res. 2002. PMID: 12154029

4

Adenovirus-mediated soluble FLT-1 gene therapy for ovarian carcinoma.

Mahasreshti PJ, Navarro JG, Kataram M, Wang MH, Carey D, Siegal GP, Barnes MN, Nettelbeck DM, Alvarez RD, Hemminki A, Curiel DT. Mahasreshti PJ, et al. Clin Cancer Res. 2001 Jul;7(7):2057-66. Clin Cancer Res. 2001. PMID: 11448924

5

Intravenous delivery of adenovirus-mediated soluble FLT-1 results in liver toxicity.

Mahasreshti PJ, Kataram M, Wang MH, Stockard CR, Grizzle WE, Carey D, Siegal GP, Haisma HJ, Alvarez RD, Curiel DT. Mahasreshti PJ, et al. Clin Cancer Res. 2003 Jul;9(7):2701-10. Clin Cancer Res. 2003. PMID: 12855650

6

Infectivity enhanced adenoviral-mediated mda-7/IL-24 gene therapy for ovarian carcinoma.

Leath CA 3rd, Kataram M, Bhagavatula P, Gopalkrishnan RV, Dent P, Fisher PB, Pereboev A, Carey D, Lebedeva IV, Haisma HJ, Alvarez RD, Curiel DT, Mahasreshti PJ. Leath CA 3rd, et al. Gynecol Oncol. 2004 Aug;94(2):352-62. doi: 10.1016/j.ygyno.2004.04.028. Gynecol Oncol. 2004. PMID: 15297172

7

Ovarian cancer targeted adenoviral-mediated mda-7/IL-24 gene therapy.

Mahasreshti PJ, Kataram M, Wu H, Yalavarthy LP, Carey D, Fisher PB, Chada S, Alvarez RD, Haisma HJ, Dent P, Curiel DT. Mahasreshti PJ, et al. Gynecol Oncol. 2006 Mar;100(3):521-32. doi: 10.1016/j.ygyno.2005.08.042. Epub 2005 Oct 12. Gynecol Oncol. 2006. PMID: 16225913

8

Vascular endothelial growth factor reduces tamoxifen efficacy and promotes metastatic colonization and desmoplasia in breast tumors.

Qu Z, Van Ginkel S, Roy AM, Westbrook L, Nasrin M, Maxuitenko Y, Frost AR, Carey D, Wang W, Li R, Grizzle WE, Thottassery JV, Kern FG. Qu Z, et al. Cancer Res. 2008 Aug 1;68(15):6232-40. doi: 10.1158/0008-5472.CAN-07-5654. Cancer Res. 2008. PMID: 18676847 Free PMC article.

9

A phase I trial of the single-chain immunotoxin SGN-10 (BR96 sFv-PE40) in patients with advanced solid tumors.

Posey JA, Khazaeli MB, Bookman MA, Nowrouzi A, Grizzle WE, Thornton J, Carey DE, Lorenz JM, Sing AP, Siegall CB, LoBuglio AF, Saleh MN. Posey JA, et al. Among authors: carey de. Clin Cancer Res. 2002 Oct;8(10):3092-9. Clin Cancer Res. 2002. PMID: 12374676 Clinical Trial.

10

Comparison of biodistribution, dosimetry, and outcome from clinical trials of radionuclide-CC49 antibody therapy.

Meredith R, Shen S, Macey D, Khazaeli MB, Carey D, Robert F, LoBuglio A. Meredith R, et al. Cancer Biother Radiopharm. 2003 Jun;18(3):393-404. doi: 10.1089/108497803322285134. Cancer Biother Radiopharm. 2003. PMID: 12954125

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters